Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
Cancer Research|September 15, 1993
Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analoguesM I Berggren, A Gallegos, L A Dressler, et al.
Investigational New Drugs|April 1, 1988
In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubationJ I Brodfüehrer, D J Moore, D C Melder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic studyR N Harris, P J Basseches, P L Appel, et al.
Cancer Communications|January 1, 1989
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblastsM J Seewald, J J Schlager, R A Olsen, et al.
Archives of Biochemistry and Biophysics|July 27, 2001
Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicinM I Berggren, B Husbeck, B Samulitis, et al.
Cancer Research|February 1, 1984
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell linesM C Alley, G Powis, P L Appel, et al.
Toxicology and Applied Pharmacology|November 1, 1989
Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxidesD J Moore, K P Batts, L L Zalkow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Cellular pharmacology of D-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activityG Brunn, A H Fauq, S Chow, et al.
Biochemical Pharmacology|August 1, 1987
Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicityG Powis, K L See, K S Santone, et al.
The Journal of Biological Chemistry|August 28, 1999
Regulation of human thioredoxin reductase expression and activity by 3'-untranslated region selenocysteine insertion sequence and mRNA instability elementsJ R Gasdaska, J W Harney, P Y Gasdaska, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Cancer Research|September 15, 1993
Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analoguesM I Berggren, A Gallegos, L A Dressler, et al.
Investigational New Drugs|April 1, 1988
In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubationJ I Brodfüehrer, D J Moore, D C Melder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic studyR N Harris, P J Basseches, P L Appel, et al.
Cancer Communications|January 1, 1989
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblastsM J Seewald, J J Schlager, R A Olsen, et al.
Archives of Biochemistry and Biophysics|July 27, 2001
Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicinM I Berggren, B Husbeck, B Samulitis, et al.
Cancer Research|February 1, 1984
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell linesM C Alley, G Powis, P L Appel, et al.
Toxicology and Applied Pharmacology|November 1, 1989
Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxidesD J Moore, K P Batts, L L Zalkow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Cellular pharmacology of D-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activityG Brunn, A H Fauq, S Chow, et al.
Biochemical Pharmacology|August 1, 1987
Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicityG Powis, K L See, K S Santone, et al.
The Journal of Biological Chemistry|August 28, 1999
Regulation of human thioredoxin reductase expression and activity by 3'-untranslated region selenocysteine insertion sequence and mRNA instability elementsJ R Gasdaska, J W Harney, P Y Gasdaska, et al.
Pageof 27